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ABSTRACT
Healthcare reforms are often not coupled with a
relevant and appropriate monitoring framework, leaving
policymakers and the public without evidence about
the implications of such reforms.
Kazakhstan has embarked on a large-scale reform of
its healthcare system in order to achieve Universal
Health Coverage. The health-related 2020 Strategic
Development Goals reflect this political ambition. In a
case-study approach and on the basis of published and
unpublished evidence as well as personal involvement
and experience (A) the indicators in the 2020 Strategic
Development Goals were assessed and (B) a ‘data-
mapping’ exercise was conducted, where the WHO
health system framework was used to describe the
data available at present in Kazakhstan and comment
on the different indicators regarding their usefulness
for monitoring the current health-related 2020 Strategic
Development Goals in Kazakhstan.
It was concluded that the country’s current
monitoring framework needs further development to
track the progress and outcomes of policy
implementation. The application of a modified WHO/
World Bank/Global Fund health system monitoring
framework was suggested to examine the implications
of recent health sector reforms. Lessons drawn from
the Kazakhstan experience on tailoring the suggested
framework, collecting the data, and using the generated
intelligence in policy development and decision-making
can serve as a useful example for other middle-income
countries, potentially enabling them to fast-track
developments in the health sector.
INTRODUCTION
Reforming a healthcare system is always a
complex undertaking, characterised by con-
ﬂicting interests and limited evidence, and it
is often not known whether well-intended
initiatives will improve people’s lives.1
Since such complexity and uncertainty can
be found in most development and reform
projects, the United Nations has launched
a large-scale ‘data revolution for sustainable
development’ in order to provide the right
information for designing, monitoring and
evaluating effective policies.2 The WHO, in
collaboration with the World Bank and the
Global Fund, published a comprehensive oper-
ational framework on the monitoring and evalu-
ation of health systems strengthening.3 In 2010,
the WHO presented ‘Monitoring the Building
Blocks of Health Systems: A Handbook of
Indicators and Their Measurement Strategies’.4
In 2014, the WHO and The World Bank pub-
lished a framework for monitoring Universal
Health Coverage (UHC) as part of a compre-
hensive framework for monitoring national
health system performance at national and
international levels with guiding principles
and methodological considerations.5 The
need for encompassing Civil Registration and
Vital Statistics as a core component of sustain-
able development has also been emphasised.6
The importance of effective and comprehen-
sive measurement of change in health
systems is increasingly being recognised.
Key questions
What is already known about this topic?
▸ Healthcare reforms are always complex and thus
require feedback about their impact.
▸ Healthcare policy initiatives are often not
coupled with a relevant and applicable monitor-
ing framework.
What are the new findings?
▸ The existing national monitoring concept was
reviewed and found to have substantial short-
comings in the health policy aspects covered
and the usefulness of indicators.
▸ A simplified framework was presented, coupling
national needs and the comprehensive monitor-
ing framework developed by the WHO, the
World Bank and the Global Fund.
Recommendations for policy
▸ Initiate a dialogue about the appropriateness of
the suggested framework with national counter-
parts, develop national capabilities and apply the
simplified framework to feedback results.
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Research
In this paper, the health reform experience in
Kazakhstan is used as a case study to explore what data
are needed for the meaningful monitoring of reforms.
The ﬁndings contribute to the global debate on meas-
urement and data production for development in the
health sector.
The following section (Theoretical background and
methods) provides a theoretical background both for
monitoring the implications of policy changes and the
case study approach taken. Context: healthcare in
Kazakhstan section then sets the context, giving a brief
overview of the Kazakh health system and recent reforms.
Next, the ﬁndings of the monitoring framework as applic-
able to Kazakhstan and available data are presented
(section Findings). The discussion (section Discussion)
presents the development of a comprehensive yet man-
ageable monitoring and assessment framework. Finally, in
the Conclusion section, we conclude what could be learnt
from the Kazakh experience and provide the outlook for
further developments.
THEORETICAL BACKGROUND AND METHODS
Monitoring the implications of policy changes—a
framework
Given that health policy is frequently not evidence-driven,7
policymaking regarding the provision and ﬁnancing of
healthcare is often as much based on the perceptions of
politicians, the inﬂuence of advisors and personal empir-
ical evidence from healthcare systems elsewhere as it is on
rigorous analysis and systematic identiﬁcation of strengths
and weaknesses of the status quo. Furthermore, the ‘meas-
urement of success’ of health ﬁnancing and delivery
arrangements is still in its infancy.1 Figure 1 depicts the
most general approach to looking at a healthcare system,
starting from ideas and taking outcomes as the ﬁnal goal.
Several approaches have been developed to establish a
conceptual framework with a clear distinction between
objectives and instruments, that is, between what the
system does and what the system is trying to achieve.8
One of the most widely used frameworks is based on (A)
the WHO’s six building blocks of any healthcare system, a
mix of inputs, processes and management issues4 and
(B) the core functions of a health system: Improved health
(both level and equity), responsiveness and ﬁnancial
protection (see ﬁgure 2).9 10 This framework is simple
yet allows one to capture structures, processes and
results.
Formal progress towards UHC assessed by intermedi-
ate goals will not automatically mean better population
health,11 so measuring effects at the population level
will be as important as measuring intermediate indica-
tors like equitable ﬁnancing and access.12 13 Resonating
with its strategy of consolidating and unifying data col-
lection and evaluation for health systems worldwide, the
WHO in collaboration with the World Bank and the
Global Fund in 2009 published a comprehensive oper-
ational framework on the monitoring and evaluation of
health systems strengthening based on the International
Health Partnership (IHP+) common evaluation frame-
work (ﬁgure 3).3 5
This concept was taken up again in 2010 with a hand-
book on suitable indicators and measurement strategies
‘for monitoring performance and evaluating progress in
the scale-up for better health’.4
The recent UN initiative on the ‘data revolution’ has
put forward the importance of data for sustainable dev-
elopment. ‘Data are the lifeblood of decision-making and
the raw material for accountability. Without high-quality
data providing the right information on the right things
at the right time; designing, monitoring and evaluating
effective policies becomes almost impossible’.2
Method: the case study approach
We use the case study approach14 primarily to describe
the current context and need for policy monitoring in
Kazakhstan. On the basis of our personal involvement
and experience, we (A) assessed the indicators in relation
to national policy in Kazakhstan and (B) conducted a
data-mapping exercise, where we used the WHO health
system framework to describe the data available in
Kazakhstan and to comment on their usefulness in aug-
menting the health-related 2020 Strategic Development
Goals in Kazakhstan.
‘The case study approach allows in-depth, multi-
faceted explorations of complex issues in their real-life
settings.’14 It has only recently become more widely used
in health service research. Early examples of the case
Figure 1 Ideas, interests and institutions in healthcare. Source: Modified after.1
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study approach in health policy have been more descrip-
tive with little theory15 or have emphasised the personal
involvement and experience of the authors.16 Later
research has tried to provide a more nuanced theoret-
ical grounding and combined methods from the social
sciences with an epistemological reﬂection and estab-
lished processes for ensuring rigour in case study and
qualitative data collection and analysis.17 18 We used pub-
licly available data together with non-classiﬁed informa-
tion that has not been published. In addition, we
conducted a literature search in PubMed, Google
Scholar and general Internet search engines with the
combination of key words ‘Kazakhstan’ AND ‘public
health’ OR ‘health care’ OR ‘epidemiology’ AND ‘data’
OR ‘monitoring’.
The case study team based the assessment of the
current health-related indicators in the national 2020
Strategic Development Goals on three categories. A
trafﬁc light system was used with red indicating that the
target could only be assessed subjectively and would thus
be prone to discussion and criticism; yellow indicated
that some element of veriﬁable assessment was possible,
whereas green indicated clear (and often easy) measure-
ment. To the best of our knowledge, such an assessment
has not been done elsewhere, but this categorisation is
self-explanatory and can easily be replicated. There is a
need for such assessment of usefulness and measurabil-
ity because unspeciﬁc, unclear and simply unmeasurable
indicators are counterproductive.
CONTEXT: HEALTHCARE IN KAZAKHSTAN
Kazakhstan is a middle-income country that aims to
become a member of the Organization for Economic
Cooperation and Development (OECD) by 2050. The
national strategy ‘Kazakhstan 2050’ has set strategic goals
for further development of the country in all areas of
social and economic development.19 It is one of the
least densely populated countries in the world with only
six people per square kilometre on average. Kazakhstan’s
Figure 2 The WHO Health System Framework with building blocks and goals outcomes. Source: Adopted from.4
Figure 3 The results framework for health system strengthening monitoring and evaluation. Source: Modified from.3
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Gross Domestic Product (GDP) was United States Dollar
(USD) 218 billion, or USD 12 600 per capita, in 2014.20
The country's GDP is to a large degree dependent on
mineral resources, and thus the economy is particularly
prone to external shocks. However, the country has a low
public debt of just 12% of GDP.21
Kazakhstan’s current state of health and health care
provision
Compared to countries in the OECD and even fellow
post-Soviet states, key population health indicators in
Kazakhstan are at the lower end (see table 1). However,
the government of Kazakhstan has acknowledged this
and has made progress in the ﬁeld of healthcare provi-
sion an explicit target of state policy.22
The country inherited a Semashko-style healthcare
system, which has an integrated approach to providing
and ﬁnancing care with primary healthcare and the dis-
trict physician at the centre, a strong referral system and
an extensive hospital network. From 1970, the system
was not able to respond to demand for better quality
care and new medical technologies. A move towards spe-
cialisation in outpatient care led to a much-reduced role
of the district physician and direct access to specialist
care, but this resulted in unmet demand for quality
care.23 At the same time, despite substantial reductions
in the past decade, hospitalisation rates remain well
above OECD levels.24 Very soon after independence
from the Soviet Union in 1991, private medical practice
was allowed in Kazakhstan and the country started an ill-
fated attempt to introduce mandatory health insurance
(1996–1998).25 Since 2000, the country has initiated
two comprehensive reform programmes: the National
Programme for Health Care Reform and Development
2005–2010 and the State Health Care Development
Programme for 2011–2015 (‘Salamatty Kazakhstan’) with
the speciﬁc aims of reducing the size of the hospital
sector and strengthening primary healthcare.25
Funding health care
At present, health funds are collected by the central gov-
ernment through general taxation and then either used
for paying providers directly or transferred to regional
authorities to cover medical services for ‘socially import-
ant diseases’ (like tuberculosis). In addition, there are
speciﬁc healthcare budgets at the local authority level.25
National level budget expenditures amount to 62.9%
and local budget expenditures amount to 37.1% of total
government health expenditures (2013 National Health
Accounts (NHA) by the Ministry of Healthcare and
Social Development and Republican Centre for Health
Development, latest NHA not yet published). When com-
paring Kazakhstan’s expenditure on health with other
Eastern European, post-Soviet countries or the OECD
average, Kazakhstan stands out as a country that spends a
relatively low share of its GDP on health (see table 2). It
seems that the provision of universal high quality services
with this level of funding might pose a serious challenge.
The government of Kazakhstan is aware of the below-
average healthcare spending. A substantial increase in the
health budget as well as a comprehensive budget review
has been identiﬁed as one of the key factors for improv-
ing ﬁnancial protection and better service levels in the
Kazakh health sector.26
Healthcare reform
There is a strong political will to pursue health sector
reform. With multiple levels of immediate (Salamatty
Kazakhstan 2011–2015), medium-term (Vision 2020 and
2030) and long-term (Kazakhstan 2050 Strategy) policy
plans,22 there is also a clear time frame with deﬁned
objectives for health sector reform. While reform efforts
are aimed at all building blocks of the healthcare system
(K Obermann, T Chanturidze, B Tokezhanov, et al.
Reforming the health system in Kazakhstan: A review
based on WHO’s concept of ‘building blocks’. Manuscript
submitted), one central theme is the introduction of
shared responsibility for health.27 In this context, shared
Table 1 Population health indicators in selected former
Soviet Union countries/Eastern European countries
Country
Life
expectancy
at birth
(years)
[2012]
Infant MR
(per 1000
live-births)
[2013]
Maternal MR
(per 100 000
live-births)
[2013]
Moldova 68.7 13.3 21
Kazakhstan 69.6 14.6 26
Kyrgyz
Republic
70.0 21.6 75
Russian
Federation
70.5 8.6 24
Ukraine 70.9 8.6 23
Georgia 73.9 11.7 41
Bulgaria 74.3 10.1 5
Romania 74.6 10.5 33
Macedonia,
FYR
75.0 5.8 7
Hungary 75.1 5.2 14
Serbia 75.2 5.8 16
Poland 76.8 4.5 3
Croatia 76.9 3.8 13
Czech
Republic
78.1 3.9 5
Slovenia 80.1 2.3 7
OECD
average
80.4 4.1 (2011) 11 (2010)
The World Bank Database (2014)—rounded values, OECD (2015),
infant mortality rates, maternal mortality rates, doi: 10.1787/
83dea506-en; doi.org/10.1787/888932722981 (Accessed on 27
October 2015).
FYR, Former Yugoslav Republic; MR, mortality rate; OECD,
Organization for Economic Cooperation and Development; TB,
tuberculosis.
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responsibility for health refers to the idea that workers,
employers and the government all participate equally in
the ﬁnancing of healthcare and the maintenance of
public health and healthy lifestyles. A key reform element
is the plan to introduce a mandatory contribution compo-
nent, akin to a SHI, into the current tax-ﬁnanced health
system. The country is not seeking to introduce SHI with
the objective of completely redesigning the ﬁnancing of
its healthcare system, but rather the augmentation of an
existing healthcare system with elements of a SHI
scheme.28 If the reforms are to maintain their momen-
tum and culminate in sustainable improvements, dedi-
cated measurement of change is needed as well as
timely interpretation of the results that allows these
changes to be explained and suggests future action.
FINDINGS
The government of Kazakhstan released a ‘National
Health Strategy 2020’ approved by Presidential Decree
No. 922 of 1 February 201022 25 with the primary aim of
improving the accessibility and quality of health services.
This is to be done via speciﬁc healthcare investment
plans, broader health ﬁnancing and more efﬁcient pro-
vider payment systems. Healthy lifestyles are supposed to
be an integral part of overall health policy. The Kazakh
government is determined to measure the impact of its
policies and has detailed its ambitions in the ‘Program
Realisation Indicators’ of the Salamatty Kazakhstan
Programme.
The goals of the strategy are reasonable and could be
expected to result in improvements in the health of the
population. However, looking at the concrete targets
deﬁned in the strategy, it becomes clear that they are for
the most part rather imprecise. Most aim only for an
increase or decrease in a certain indicator or the imple-
mentation of a policy, without specifying the current
baseline and the degree of improvement that is desired.
For example, internal data show that one of the product-
ivity indicators of the NHA, the ‘number of operations
per 1 million Tenge’, had a tendency to fall between
2010 and 2013. This could either be interpreted as a
drop in efﬁciency or, quite to the contrary, be connected
to the improvement of hospital infrastructure, allowing
for more complex and expensive operations. A detailed
technical analysis is required to ensure that policymakers
interpret these indicators appropriately.
The assessment of health-related indicators in the
2020 Strategic Development Goals is based on their use-
fulness and measurability as described above (red: target
can only be assessed subjectively and will thus be prone
to discussion and criticism; yellow: some element of veri-
ﬁable assessment is possible; green: clear—and often
easy—measurement) and is presented in table 3.
Whereas population health is well covered overall,
there is no mention of equity between different popula-
tion groups. The possible ﬁnancial burden when
seeking healthcare is also not covered in the national
health strategy. However, both issues are extensively dis-
cussed in the social health insurance (SHI) concept and
the draft SHI Law, as submitted to the Parliament, spe-
ciﬁcally aims to address ﬁnancial equity in the system.
In the data mapping exercise (see table 4), we
describe the data available at present in Kazakhstan and,
using the available evidence, comment on the different
indicators regarding their usefulness to augment the
current health-related 2020 Strategic Development
Goals in Kazakhstan. Data are in principle available in
Kazakhstan for most of the measurements recom-
mended by the WHO. Data are currently lacking for the
General and Speciﬁc Service Readiness Scores and for
the Health Information System Performance Index. A
Health Facility Assessment has been conducted in order
to obtain data on the Readiness Scores, but as of
October 2015 no data were available. These data would
also provide up-to-date information on the availability of
essential medicines, which is a key objective of the 2020
Strategic Development Goals, and would allow for
regional differentiation of workforce and infrastructure
data. The Health Information System Performance
Index so far has not been used.
DISCUSSION
This case study indicates that the standard WHO/World
Bank/Global Fund health policy monitoring framework
Table 2 Total health expenditures in selected Former
Soviet Union countries/Eastern European countries and
OECD average (2012 Data)
Country
Total health expenditure
(as % of GDP)
Kazakhstan 4.2
Romania 5.1
Russian Federation 6.3
Poland 6.7
Croatia 6.8
Kyrgyz Republic 7.1
Macedonia, FYR 7.1
Bulgaria 7.4
Ukraine 7.6
Czech Republic 7.7
Hungary 7.8
Slovenia 8.8
Georgia 9.2
Serbia 10.5
Moldova 11.7
OECD average 8.9
The World Bank Database (2014)—rounded values; OECD health
expenditure database.
The total health expenditure is around 3.8% according to the latest
National Health Account.
FYR, Former Yugoslav Republic; GDP, Gross Domestic Product;
OECD, Organization for Economic Cooperation and Development.
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Table 3 Kazakhstan’s health-related 2020 Strategic Development Goals
By 2015 By 2020 (Comments)
Major health indicators
Increase in average life expectancy To 69 years To 72 years
Decrease in maternal mortality By 1.5 times By 2 times (mathematically imprecise;
percentages would have been better)
Decrease in infant mortality By 1.5 times By 2 times (mathematically imprecise;
percentages would have been better)
Decrease in overall mortality By 15% By 30%
Decrease in TB incidence By 10% By 20%
Health system financing and management
Introduction of free choice of doctor and provider X (yes/no)
Creation of conditions for equal access to medical services
within SGBP regardless of the place of residence
X (yes/no) (Major weakness; more specific targets
should be formulated)
Reduction in rates of informal payments X (yes/no)
Introduction of co-payment mechanisms together with the
existing SGBP system
X (yes/no) (OOP already high)
Development of a system to assess the efficiency of
healthcare investments
X (yes/no) (Complex; how to define outcomes?)
Introduction of an effective tariff policy X (yes/no) [Definition of ‘effective’?]
Creation of efficient health financing and provider payment
systems, based on a prioritised development of
socially-oriented primary care
X (yes/no) (vague and nondescript)
Creation of a modern health management system, meeting
international standards
X (yes/no) (vague and nondescript)
Introduction of new mechanisms to increase shared
responsibility of the population for health
X (yes/no) (vague and nondescript)
Healthcare delivery system
Increase in share of primary healthcare services provided by
general practitioners to 30% of outpatient services
X (yes/no)
Increase in the share of inpatient services provided by
general hospitals rather than more specialised facilities
X (yes/no) (No clear targets set)
Increase in expenditure on primary healthcare by 40% of the
overall funding of the SGBP
X (yes/no)
Major indicators of inpatient services providers (bed turnover,
ALOS) to meet international effectiveness standards
X (yes/no) (No clear targets set)
Accessibility and quality of drugs
Increase in accessibility of drugs and medical supplies used
for SGBP provision, particularly in rural areas
X (yes/no) (Major weakness; more specific targets
should be formulated)
Introduction of state regulation of the price of drugs procured
for state-run health facilities
X(yes/no)
Introduction of an effective provision system for drugs and
medical supplies within the SGBP
X (yes/no)
Healthy lifestyles
Increase in physical activity and sports in the general
population
To 25% To 30%
Increase in physical activity and sports in children and youth To 12% To 15%
Decrease in smoking, drug use and alcohol abuse By 15%
General acceptance of the importance of a healthy lifestyle
among the population
X (yes/no) (Major weakness; more
specific targets should be formulated)
OOP, out of pocket payments; SGBP, state guaranteed benefit package; ALOS, average length of stay.
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Table 4 Monitoring the implications of health policy changes in Kazakhstan based on the WHO health system framework: a summary of available data and suggestions for
the health-related 2020 Strategic Development Goals
Measurement aspect Available data Comments based on the available evidence
Governance
Willingness for reform (eg, availability of
laws, policy documents)
Salamatty Kazakhstan (2011–2015); Kazakhstan Social
Development Concept of 24 April 2014 (Resolution№396);
Presidential address from 17 January 2014
There is no clear consensus on the appropriate values for
these indicators in any given health system.
Should not be included
Trust in government institutions (general/
health)
Survey data needed
Public expenditure tracking (PETS) in
place
No PETS study carried out so far To be carried out in order to assess flow of funds
Per cent of budget with defined
responsibility central/local level
Overall: 62.9% central level, 37.1% oblast level (2013 NHA by
MHSD and RCHD)
No added policy value
% admin cost of total government health
spending
Not available Helpful indicator, administration cost need to be estimated
Corruption Perception Index (general/
health-specific)
General: Transparency International 2013: 26 of 100 points, rank
no. 140 worldwide. Health: Corruption Perception Index, some
older data available37 38
Rather general; not helpful for policy assessment
Use of one purchaser or many Two purchasers: MHSD and oblast health authorities A political one-off decision; no need to measure
Financing
Total expenditure on health As share of GDP: 4.2% (2012)*; 3.5% (2011), 3.8% (2012), 3.5%
(2013)—NHA by MHSD and RCHD
To be included; specific target needs to be set
GGHE as a proportion of GGE GGHE/GGE: 10.9 (2012)*; GGHE as % of GGE 12.1% (2011),
12.3% (2012), 11.6% (2013) –NHA by MHSD and RCHD
To be included; specific target needs to be set
The ratio of household OOP payments
for health to total expenditure on health
OOP as share of THE: 41.7%(2012)* 28.2% (2011), 30.2%
(2012), 32.7% (2013) –NHA by MHSD and RCHD
To be included; specific target needs to be set
Health Workforce
Health workers/100 000 population Physicians: 349.5; Dentists: 41.2; Pharmacists: 80.6; Nurses:
804.5; Midwives: 57.73 (2012)†
To be included; specific targets need to be set
Distribution of health workers by
occupation/specialisation, region
GPs: 31/100‘000 (2011 WHO HFA-DB) Data available from some oblasts (regions); collection and
publishing of this data should be consolidated. To be
included, specific targets need to be set
Graduates of health professions
institutions/ 100 000 population (level/
field of education)
Physicians graduated/100 000: 21.86 (2010)† Quantity is not a key concern; more important is quality,
thus not included
Health Information Systems
Health information system performance
index
Not available The WHO recommends compiling the index based on:
1. Health surveys
2. Birth/death registration
3. Census
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Table 4 Continued
Measurement aspect Available data Comments based on the available evidence
4. Health facility reporting
5. Health resource tracking
6. Capacity for analysis
To be included; specific targets need to be set
Service delivery
General Service readiness score for
health facilities
Countrywide assessment has been initiated but results are not yet
available
The WHO recommends Health Facility Assessment,
including:
1. Basic amenities
2. Basic equipment
3. Standard precautions for infections prevention
4. Laboratory
5. Medicines and commodities
To be included; specific target needs to be set
Proportion of health facilities offering
specific services(/10 000 population)
ditto
Specific-services readiness score for
health facilities
ditto
Service quality
Accreditation and external quality
management
For providing the SGBP, a health facility must pass accreditation.
Accreditation by the Committee for Control of Pharmaceutical and
Medical Activities (MHSD), recognised by ISQua Standards for
Facilities
To be included; specific target needs to be set
Involving public/private providers At present, limited involvement of private providers via state
budget; 811 public and 428 private providers
Unspecific indicator; no optimal level defined
Personnel (qualification, number);
staffing index/ratio; competency index
Countrywide assessment has been initiated but results are not yet
available
In principle, helpful to monitor availability and quality of
staff
Utilisation
Use of specific preventive measures Data currently not available Already included
Benefit catalogue (needs, economic
evaluation)
State-guaranteed benefit package (SGBP) very comprehensive,
but not yet evaluated
No need for monitoring
Support value (% of total cost paid) Not applicable Relevant intermediate indicator, especially with the
planned SHI (financial protection)
Benefit Incidence Analysis (BIA) Household survey has been conducted, but so far not fully
analysed
To be included; specific target needs to be set
Accessibility (e.g. geographical; no. of
providers; time to get to a provider for
Caesarean section)
Household survey has been conducted, but so far not fully
analysed
Relevant intermediate indicator for planning
Access to essential medicines
Average availability of selected essential
medicines in public and private health
facilities
Median availability (private): 70%
Median availability (public): 0% (2004)*
10-year-old data for drug prices and availability; a new
survey is required to determine whether performance is
still this poor.
Continued
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Table 4 Continued
Measurement aspect Available data Comments based on the available evidence
To be included; specific target needs to be setMedian consumer price ratio of selected
essential medicines in public and private
facilities
Price ratio (private): 3.73
Price ratio (public): 4.84 (2004)*
Health level
Risk factor prevalence To be included; specific target needs to be set
Average life expectancy 69.6 years39 Already included
Maternal mortality 26/100 000 live-births39 Already included
Infant mortality 14.6/1000 live-births39 Already included
Overall mortality Analysis for different ethnicities40 41, regions42 and age
groups43 available.
Already included
Decrease in specific morbidity, eg, TB,
HIV/AIDS
Available from the WHO‡ Already included
Financial protection and equity
Impoverishment rate due to healthcare
expenditures
Household survey has been conducted, but so far not fully
analysed
Stratified by wealth quintile, place of residence and gender
To be included; specific target needs to be set
Kakwani index Data available for calculation None
Responsiveness
Customer Satisfaction Rating (facility) Household survey has been conducted, but so far not fully
analysed
To be included; specific target needs to be set
Overall satisfaction with health services Household survey has been conducted, but so far not fully
analysed
To be included; specific target needs to be set. Data from
2001 and 2010 available44
*Global Health Observatory Data Repository; http://apps.who.int/gho/data/node.main.488?lang=en.
†European health for all database (HFA-DB), WHO Regional Office for Europe, http://data.euro.who.int/hfadb/.
‡http://www.who.int/tb/country/en/.
GDP, Gross Domestic Product; GGE, General Government Expenditure; GGHE, General Government Expenditure on Health; MHSD, Ministry of Health and Social Development; NHA, National
Health Accounts; RCHD, Republican Centre for Health Development; SGBP, State Guaranteed Benefit Package; SHI, social health insurance.
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needs to be tailored to the country context. At the same
time, the health-related indicators presented in the
Kazakh 2020 Strategy have to be reﬁned to attain consist-
ency in quality, usefulness and measurability. On the
basis of these ﬁndings, a number of indicators, quantita-
tive and qualitative, that would fulﬁl SMART criteria
(speciﬁc, measurable, action-oriented, realistic, timely)
can be selected. In some instances, perception-based
qualitative data would be most appropriate. This mix of
approaches and methods would provide as broad a
picture as possible. In addition, equity measurements
comparing the data for the richest versus the poorest
20% of the population could be incorporated. Roberts
et al,29 in a similar vein, proposed a ‘step pyramid’ that
allows one to disaggregate the UHC cube.
A simpliﬁed WHO/World Bank/Global Fund health
policy monitoring framework would assist in examining
the effects of Kazakhstan’s ambitious health policy
reforms (ﬁgure 4).
This approach incorporates the WHO health system
framework, but differs from the WHO/World Bank/
Global Fund common evaluation concept in three
important points as (1) it does not primarily focus on
international comparability, but rather looks at monitor-
ing for the needs of the country, (2) it takes a broader
view on the key input parameters (like staff, IT, govern-
ance) rather than the composite measures of service
coverage and ﬁnancial protection and (3) it views health
equity as a cross-cutting indicator that should be looked
at throughout the delivery chain rather than assessing
equity only at the outcomes/impact level. Ambiguous
indicators, for which it would be difﬁcult to deﬁne spe-
ciﬁc targets, were left out. This framework can then be
reapplied to the health-related Strategic Development
Goals 2020 in Kazakhstan to provide a revised monitor-
ing concept (see table 5).
In addition to strengthening/implementing the
General and Speciﬁc Service Readiness Scores and the
Health Information System Performance Index, a com-
prehensive household survey would allow for more
precise health expenditure and utilisation data, stratiﬁed
by the wealth quintile, place of residence, ethnicity and
gender, which in turn could guide health policy when it
comes to speciﬁcally addressing equity issues.
As for measuring, estimating and monitoring risk
factors, the WHO’s STEPwise approach to non-
communicable disease risk factor surveillance (STEPS,
see http://www.who.int/chp/steps/riskfactor/en/) is a
well-established instrument for obtaining core data on
risk factors that determine the burden of disease. The
STEPS instrument includes a questionnaire as well as
physical and biochemical measurements and provides
concrete advice on surveillance planning, adapting and
implementing the instrument.
Owing to its simple structure and comprehensive
approach, the adopted WHO/World Bank/Global Fund
health system monitoring tool (see ﬁgure 4) seems suit-
able to determine whether reforms are aimed at the key
system features needed for the provision of quality
healthcare. However, such a monitoring concept has so
far not been used to evaluate reform agendas with
respect to their coverage of essential health system fea-
tures. This novel approach derived from the Kazakh
experience should be tried and tested in other contexts
as there is a clear gap between policy initiatives and
measuring the effects they have.
Figure 4 The modified WHO health system monitoring tool: Assessing inputs and processes, outputs, outcomes and impact.
Source: Authors.
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Table 5 A revised monitoring concept for the health-related Strategic Development Goals 2020 in Kazakhstan
Indicator Status/data Equity measure suggested
Governance
Development of a system to assess the efficiency of healthcare
investments
Existing None
Public expenditure tracking (PETS) in place New None
% admin cost of total government health spending New None
Financing
Introduction of a free choice of providers Existing None
Total expenditure on health New Top 20% vs bottom 20% of SES
GGHE/GGE New
Ratio of household OOP to total health expenditure New
Health workforce
Health workers/100 000 population New By region, specialisation
Personnel staffing index/ratio; competency index New By region; urban vs rural
Health information systems
Health information system performance index New By region
Service delivery
Accessibility (geographical) New By region; urban vs rural
Primary healthcare is 30% of all outpatient services Existing
40% of the SGBP funding goes to primary healthcare Existing
Introduction of an effective tariff policy Existing None
Increase in the share of inpatient services provided by general hospitals
rather than more specialised facilities
Existing By region; urban vs rural
General Service readiness score for health facilities New By region; urban vs rural
Service quality
Major health system performance indicators (bed turnover, ALOS) meet
international standards
Existing By region; urban vs rural
Accreditation and external quality management New
Utilisation
Increase in physical activity and sports in the general population Existing Top 20% vs bottom 20% of SES by
region; by ethnicity; by gender
urban vs rural
Increase in physical activity and sports in children and youth Existing
Decrease in smoking, drug use and alcohol abuse Existing
Benefit incidence analysis New
Financial protection
Support value (% of total cost paid) New Top 20% vs bottom 20% of SES by
region; by ethnicity; by gender
urban vs rural
Impoverishment rate due to healthcare expenditures New
Access to essential medicines
Introduction of state regulations for the price of drugs procured for
state-run health facilities
Existing None
Introduction of an effective provision system for drugs and medical
supplies within the SGBP
Existing None
Average availability of selected essential medicines in public and private
health facilities
New By region; urban vs rural
Median consumer price ratio of selected essential medicines in public
and private health facilities
New
Health level
Increase in average life expectancy Existing
Decrease in maternal mortality Existing
Continued
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It is both a scientiﬁc and a political question to deﬁne
what constitutes an improvement and what goals should
ideally be achieved by which means. The proposed
framework should thus be viewed as a suggestion and
stimulus for health policy debate in order to support pol-
icymakers and administrators in working for better
health, more equitable health and better ﬁnancial protec-
tion while taking into account the non-medical needs of
the population.
CONCLUSION
Kazakhstan’s goal to provide universal healthcare cover-
age for its population is laudable and much needed, but
challenging to achieve. While reform efforts have been
under way for some time, overall population health indi-
cators still show signiﬁcant room for improvement. A key
philosophy that Kazakhstan hopes to put into action is
the concept of ‘shared responsibility for health’. The
current plans for imbedding mandatory SHI, in a pri-
marily tax-funded health system, would formally demon-
strate the ideal of this concept (although a tax-based
system is also based on the idea of solidarity). At the
same time, the proposed SHI reform could potentially
tackle many of the current challenges faced by Kazakhstan’s
health system. It might stimulate an increase in total
health expenditure, bringing it closer to levels required
to meet Kazakhstan’s healthcare objectives. It may also
prove to be a major step forward in improving the pur-
chase and provision of healthcare under the general
notion of a shared responsibility for health. A stand-
alone health ﬁnancing reform, however, will not resolve
the numerous challenges in the sector. The Government
will need to assess and review the service organisation and
delivery practices and, in some cases, build on the best
practices of the ‘Semashko’ system simultaneously. For
example, strengthening the polyclinic model might be a
valuable element in improving the provision of care,23 as
well as in building up strong public health systems on the
concept of the sanitary-epidemiological system, used
throughout the former Soviet Union.30
In this complex endeavour, the inability to measure
progress towards policy objectives will seriously hamper
visualising and effectively communicating the value and
implications of the proposed reforms. The modiﬁed
WHO/World Bank/Global Fund health system analysis
framework could be linked to the country’s 2020 Strategic
Development Plan to form the basis for a revised moni-
toring framework including new potential data sources
and possible measures for equity.
Making full use of such a framework, however, re-
quires primary collection as well as tailor-made studies
and surveys that will require substantial capacity develop-
ment. If the Government of Kazakhstan wants to assess
and publish the impact of health ﬁnancing reforms,
resources need to be clearly designated to ﬁne-tune and
use these instruments. Systematic monitoring, assess-
ment and transparency will be key technical aspects
for visualising and communicating the implications of
health ﬁnancing reforms with respect to tangible health
beneﬁts for the population. This has been successfully
implemented in other settings such as Bangladesh.31
Since Kazakhstan is a vast country with a partially but
not fully developed infrastructure for health information
management systems, there is potential to leap forward
in embracing information technologies in a way that
might go well beyond current uses.32
Keeping equity in the picture throughout assessing
the delivery process, ﬁnancing and overall results is an im-
portant part of health system analysis (see for examplean
analysis on the effects of introducing national health insur-
ance in Taiwan33 and Thailand.34 By setting more concrete
overall goals and incremental targets, with clear deﬁnitions
for success and/or failure, Kazakhstan’s government
would be able to continuously track progress and bottle-
necks in the reform process. Reporting positive changes
can help to attain a broad acceptance of health policy
initiatives in the country as reported from Georgia.35
Recent international and regional developments (eco-
nomic slowdown in neighbouring Russia/China and
conﬂict in Ukraine) as well as the drop in global oil and
gas prices36 have had a major inﬂuence on the country’s
economy. The GDP has fallen from US$231 billion in
2013 to US$218 billion in 2014,20 and this has led
Kazakhstan to revise its growth targets downward as well
as reviewing the state budget in order to achieve ﬁscal
consolidation—this is a time when a government’s com-
mitment to long-term and people-centred healthcare
Table 5 Continued
Indicator Status/data Equity measure suggested
Top 20% vs bottom 20% of SES by
region; by ethnicity; by gender
urban vs rural
Decrease in infant mortality Existing
Decrease in overall mortality Existing
Decrease in TB incidence Existing
Risk factor prevalence New
Responsiveness
Customer Satisfaction Rating (facility) New Top 20% vs bottom 20% of SES by
region; by ethnicity; by gender
urban vs rural
Overall satisfaction with health services New
ALOS, average length of stay; GGE, General Government Expenditure; GGHE, General Government Health Expenditure; OOP, out of packet
payments; SES, socioeconomic strata; SGBP, state guaranteed benefit package.
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reform is needed most. A well thought-of monitoring
framework and data-driven decision-making could aid in
getting the most out of limited resources.
Findings from the Kazakhstan case study, with a pro-
posed monitoring framework tailored to the country’s
needs, could also potentially be relevant for many other
middle-income countries, as it shows that with an ap-
propriate framework, data could be put together in a
policy-relevant manner, gaps could more easily be identi-
ﬁed and a quantitative basis could be provided for meas-
uring and assessing the impact of health policy reform.
However, indicators can only describe change, not explain
change. Consequently, an evaluation approach should aim
to learn from the reforms as they are implemented, and
feed this back into policy development.
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